A randomized, double-blind trial demonstrating bioequivalence of the current recombinant activated factor VII formulation and a new robust 25°C stable formulation-Reference-Cited by-同舟云学术

A randomized, double-blind trial demonstrating bioequivalence of the current recombinant activated factor VII formulation and a new robust 25°C stable formulation

Published:2007-07-12 Issue:5 Volume:13 Page:527-532
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

BYSTED B. V.,SCHARLING B.,MØLLER T.,HANSEN B. L.

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2007.01516.x/fullpdf

Reference12 articles.

1. A cell-based model of hemostasis;Hoffman;Thromb Haemost,2001

2. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery;Shapiro;Thromb Haemost,1998

3. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation;Rao;Proc Natl Acad Sci USA,1988

4. Platelet activity of high-dose factor VIIa is independent of tissue factor;Monroe;Br J Haematol,1997

5. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII;Hoffman;Blood Coagul Fibrinolysis,1998

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nothing short of a revolution: Novel extended half-life factor VIII replacement products and non-replacement agents reshape the treatment landscape in hemophilia A;Blood Reviews;2023-12

2. The Pharmacokinetics and Pharmacodynamics of A Novel Recombinant Activated Human Factor VII, GEN-0828, in Hemophilia B Mice;Journal of Pharmaceutical Sciences;2023-03

3. Factor VII and thromboembolism;Trends in Anaesthesia and Critical Care;2018-10

4. Relative and Absolute Bioavailability Study of Emicizumab to Bridge Drug Products and Subcutaneous Injection Sites in Healthy Volunteers;Clinical Pharmacology in Drug Development;2018-09-19

5. Recombinant factor VIIa and prothrombin complex concentrates to treat bleeding episodes in hemophilic patients with inhibitors: a Systematic Review;Hematology & Transfusion International Journal;2018-06-04